课题基金 / 基金详情

2014 TERMIS-AM Conference in Washington, DC on December 13-16, 2014

2014 TERMIS-AM Conference in Washington, DC on December 13-16, 2014
2014 年 TERMIS-AM 会议于 2014 年 12 月 13-16 日在华盛顿特区举行
批准号:
1439059
负责人:
John Fisher
金额:
$3.35万
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-01 至 2015-08-31

项目摘要

项目成果

John Fisher的其他基金

相似基金

相关文献

中文摘要
翻译
PI:Fisher,John P.提案编号:1439059机构:2014年12月13-16日,华盛顿特区的马里兰大学学院ParkTERMIS-AM会议本提案寻求为参加组织工程和再生医学国际学会-美洲分会(TERMIS-AM)年会的青年研究人员、研究生和本科生提供旅行奖的支持,该年会将于2014年12月13-16日在华盛顿特区举行;本次会议内的特别会议也要求提供支持。2014年TERMIS-AM会议由马里兰大学的John P.Fisher博士(会议主席)和约翰霍普金斯大学的Jennifer Elisseef博士(项目主席)组织。2014年TERMIS-AM会议的主题是“通过再生医学恢复生命”,反映了组织工程和再生医学的社会影响。除了科学会议,其中包括该领域领导人的演讲,会议还包括几个特别会议,旨在让包括NSF、NIH、FDA和NIST在内的联邦机构参与会议的规划和作为演讲者参与。组织工程和再生医学是一个新兴的交叉学科领域,有可能彻底改变各种疾病的临床治疗和治疗方法。TERMI-AM会议是组织工程和再生医学国际学会每年在美洲举行的重要年会,来自学术界和产业界的800多名研究人员、科学家、学员和学生齐聚一堂,介绍和讨论该领域的关键发展。因此,会议整合和传播了组织工程和再生医学的前沿研究。主旨演讲者是该领域的领导者,技术和海报会议包括关于最新进展的演讲。TERMIS-AM学生和青年调查员科(SYIS)将在会议规划和执行中发挥重要作用。此外,还将强调促进妇女和代表性不足的群体参与组织工程和再生医学领域。来自NSF、NIH、FDA和NIST的与会者将发表演讲,并讨论各自联邦机构在推进组织工程和再生医学的基础科学、技术和翻译方面所做的努力。会议计划为调查人员之间的互动和建立网络提供充足的机会。
英文摘要
PI: Fisher, John P. Proposal Number: 1439059 Institution: University of Maryland College ParkTERMIS-AM Conference, Washington DC, December 13-16, 2014This proposal seeks support for Travel Awards to Young Investigators, Graduate Students and Undergraduate Students to attend the Tissue Engineering and Regenerative Medicine International Society - Americas Chapter (TERMIS-AM) Annual Meeting to be held in Washington, DC on December 13-16, 2014; support is also requested for special sessions within this meeting. The 2014 TERMIS-AM Meeting is organized by Dr. John P. Fisher (Conference Chair) at the University of Maryland and Dr. Jennifer Elisseeff (Program Chair) at The Johns Hopkins University. The theme for the 2014 TERMIS-AM Meeting is "Restoring Lives through Regenerative Medicine," which reflects the societal impact of tissue engineering and regenerative medicine. Besides the scientific sessions, which include presentations by leaders in the field, the meeting includes several special sessions and aims to integrate federal agencies, including the NSF, NIH, FDA, and NIST, in the planning of and participating in the meeting as presenters. Tissue engineering and regenerative medicine is an emerging interdisciplinary field with the potential to revolutionize clinical treatments and therapies for a variety of diseases. The TERMIS-AM Meeting is the key annual meeting of the Tissue Engineering and Regenerative Medicine International Society held in the Americas each year, and brings together over 800 researchers, scientists, trainees, and students from both academia and industry to present and discuss key developments in the field. The meeting therefore integrates and disseminates cutting edge research in tissue engineering and regenerative medicine. Keynote speakers are leaders in the field and technical and poster sessions include presentations on the latest advances. A strong role in the meeting planning and execution will be played by the TERMIS-AM Student and Young Investigator Section (SYIS). Additionally, there will be an emphasis on promoting the involvement of women and underrepresented groups in the tissue engineering and regenerative medicine fields. Participants from NSF, NIH, FDA, and NIST will provide presentations and will discuss the efforts of the respective federal agencies in advancing fundamental science, technology, and translation in tissue engineering and regenerative medicine. The conference is planned to allow ample opportunities for interactions among investigators and for networking.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NSF/FDA SIR: 3D Human Stem Cell Cardiac Model for Cardiac Electrophysiology Medical Device Safety Assessment
Collaborative Research: 4D Bioprinting of Near-infrared Light Responsive Smart Constructs for Pluripotent Stem Cell Derived Cardiomyocyte Engineering
NSF/FDA Scholar In Residence: 3D Cell Adhesion Assay for Cellularized Scaffold Characterization and Enhancement
Biohybrid Strategies for Decellularized Tissues
海外基金